Skip to content
Screener

Tarsus Pharmaceuticals, Inc. TARS Restricted stock units outstanding

Restricted stock units outstanding at other companies

Aeva Technologies logo
Aeva TechnologiesAEVA
$0-100%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$730K-50.0%
Talkspace, Inc. logo
Talkspace, Inc.TALK
-$1.7M-50.7%
Talkspace, Inc. logo
Talkspace, Inc.TALK
-$1.7M-50.7%
3M logo
3MMMM
6.4K-9.9%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$0

Other financials

Income statement

See full
Revenue$173.9M+69.4%
Gross profit$161.8M+67.8%
Operating income-$19.9M+10.3%
Net income-$18.6M+8.8%
EPS (diluted)-$0.43+10.4%

Balance sheet

See full
Cash & equivalents$206.6M+108%
Total debt$88.8M+22.6%
Total equity$346.7M+4.2%
Total assets$611.1M+23.5%

Cash flow

See full
Operating cash flow$61.2M+308%
CapEx$4.1M+306%
Free cash flow$57.2M+288%

Valuation

See full
Market cap$2.97B+40.7%
Enterprise value$2.86B+36.8%
P/S4.9×-2.2×

Profitability

See full
Gross margin79.8%
Operating margin-8%-3.5pp
Net margin-7.7%-3.3pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-13.7%-4.9pp
Debt / equity0.3×0.0×
Current ratio3.2×-2.1×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:CommonStockCapitalSharesReservedForFutureIssuanceEffectOfRestrictedStockUnitsAvailableForFutureGrant.

The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:25 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001819790-26-000064
Line itemJune 30, 2026December 31, 2025
Pre-funded warrants to purchase common stock312,500312,500
Equity award plans:
Common stock awards reserved for future issuance under the 2020 and 2016 Plans7,950,7127,044,164
Common stock awards reserved for future issuance under the 2020 ESPP3,195,2622,796,609
Stock options issued and outstanding (unvested and vested) under the 2020 and 2016 Plans5,536,8335,231,125
Restricted stock units issued and outstanding (unvested) under the 2020 Plan1,574,0151,756,329
Performance stock units issued and outstanding (unvested) under the 2020 Plan706,478724,793
Total shares of common stock reserved19,275,80017,865,520

Item 1. Financial Statements

FAQ

What is Tarsus Pharmaceuticals, Inc.'s restricted stock units outstanding?
Tarsus Pharmaceuticals, Inc. (TARS) reported restricted stock units outstanding of $1.57M in Q2 2026.
How has Tarsus Pharmaceuticals, Inc.'s restricted stock units outstanding changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s restricted stock units outstanding decreased by 13.2% year-over-year, from $1.81M to $1.57M.
What does restricted stock units outstanding mean?
Restricted stock units outstanding as reported by Tarsus Pharmaceuticals, Inc. Common Stock.

Ask your AI about Tarsus Pharmaceuticals, Inc.'s restricted stock units outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude